<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[ivax corp. and patent Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/ivax+corp.+and+patent.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to ivax corp. and patent]]></description>
	<s:counts start="0" returned="4" found="4" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Miami-based generic drug maker Ivax challenges patents of Forest]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qn4189/is_20030815/ai_n10167349]]></link>
		<description><![CDATA[A Miami-based maker of generic drugs is challenging the patents of blockbuster anti-depressant drug Lexapro made by Forest Laboratories, a Manhattan company with significant Long Island operations.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 15 Aug 2003 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[Bush's Move to Lower Drug Prices Hailed, Attacked.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200210/ai_n21693606]]></link>
		<description><![CDATA[By John Dorschner, The Miami Herald Knight Ridder/Tribune Business  News    Oct. 22--With soaring healthcare costs worrying many voters,  President  Bush's preelection bid to lower drug prices was cheered  Monday by generic drug  manufacturers but was met with suspicion by some  consumer...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 22 Oct 2002 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/bush.html"><![CDATA[Bush]]></category>
		<category domain="http://resources.bnet.com/topic/generic.html"><![CDATA[generic]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/president.html"><![CDATA[president]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+senate.html"><![CDATA[U.S. Senate]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[Collusion to Stall Generics Is Subject of ETC Probe.(Federal Trade Commission launches investigation)(Statistical Data Included)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_200010/ai_n13182237]]></link>
		<description><![CDATA[Move could lead to re-examination of Hatch-Waxman.       LOOPHOLES IN AN act meant to encourage generic competition have led  Federal Trade Commission to launch a preliminary investigation of  possible anti-competitive and anti-consumer behaviors betw    Move could lead to re-examination of...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 23 Oct 2000 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agreement.html"><![CDATA[agreement]]></category>
		<category domain="http://resources.bnet.com/topic/drug+company.html"><![CDATA[drug company]]></category>
		<category domain="http://resources.bnet.com/topic/ftc.html"><![CDATA[FTC]]></category>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[Ivax, BMS Suit Up In Taxol Legal Battle.(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_200008/ai_n13311369]]></link>
		<description><![CDATA[IVAX CORPORATION and Bristol-Myers Squibb are suiting up for yet  another legal battle over a generic version of BMS's anticancer  drug Taxol paclitaxel. The current issue involves an effort by BMS to  delay the entry of generic paclitaxel through a    IVAX CORPORATION and Bristol-Myers...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 21 Aug 2000 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/orange+pcs.html"><![CDATA[Orange PCS]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
</channel>
</rss>
